StimmelGlenn L.: Clinical Pharmacy Services in Mental Health Facilities, Hospitals51: 71–74 (Jan.) 1977.
2.
DetreT. P.JareckiD. G.: Modern Psychiatric Treatment, Lippincott Co., New York, N.Y., chap. I, 1971.
3.
WoodruffR. A.Jr.GoodwinD.W.GuzeS. B.: Psychiatric Diagnosis, Oxford University Press, New York, N.Y., pp. 3–24, 1974.
4.
ShopsinB.GershonS.ThompsonH.: Psychoactive Drugs in Mania, Arch. Gen. Psychiatry32: 34–42 (Jan.) 1975.
5.
HollisterL. E.: Clinical Use of Psychotherapeutic Drugs, Charles Thomas, Springfield, Ill., chaps. 3–4, 1975.
6.
DunnerD. L.StalloneF.FieveR. R.: Lithium Carbonate and Affective Disorders, Arch. Gen. Psychiatry33: 117–120 (Jan.) 1976.
7.
BunneyW. E.WherT. R.GillinJ. C.: The Switch Process in Manic-Depressive Psychosis, Ann. Intern. Med.87: 319–335 (Sept.) 1977.
8.
TaylorM. A.GaztanagaP.AbramsR.: Manic-Depressive Illness and Acute Schizophrenia: A Clinical, Family History and Treatment Response Study, Am. J. Psychiatry131: 678–681 (June) 1974.
9.
CarlsonG. A.GoodwinF. K.: The Stages of Mania, A Longitudinal Analysis of the Manic Episode, Arch. Gen. Psychiatry28: 221–228 (Feb.) 1973.
10.
PopeH. G.LipinskiJ. F.: Diagnosis in Schizophrenia and Manic Depressive Illness, Arch. Gen. Psychiatry35: 811–828 (July) 1978.
11.
APA Task Force Report, The Current Status of Lithium Therapy, Am. J. Psychiatry132: 997–1001 (Sept.) 1975.
12.
SchouM.: Lithium in Psychiatric Therapy and Prophylaxis, J. Psychiatric Res.6: 67–95 (June) 1968.
13.
SmulevitchA. B.ZavidowskayaG. I.IgoninA. L.: The Effectiveness of Lithium in Affective and Schizo-Affective Psychoses, Br. J. Psychiatry125: 65–72 (Jan.) 1974.
14.
PokornyA. D.PrienR. F.: Lithium in Treatment and Prevention of Affective Disorder, Dis. Nerv. Syst.35: 327–333 (June) 1974.
15.
PrienR. F.KlettJ.CaffeyE. M.: Lithium Carbonate and Imipramine in Prevention of Affective Episodes, Arch. Gen. Psychiatry29: 420–425 (Sept.) 1975.
16.
FieveR. R.PlatmanS. R.HutchikR. R.: The Use of Lithium in Affective Disorders, Am. J. Psychiatry125: 487–498 (Oct.) 1968.
17.
MendelsJ.SecundaS.DysonL.: A Controlled Study of Antidepressant Effects of Lithium Carbonate, Arch. Gen. Psychiatry26: 154–157 (Feb.) 1972.
18.
HollisterL. E.: Tricyclic Antidepressants (Part I), N. Engl. J. Med.299: 1106–1109 (Nov.) 1978.
19.
HollisterL. E.: Clinical Use of Tricyclic Antidepressants, Dis. Nerv. Syst.37: 17–21 (March) 1976.
20.
ShaderR. I.: Problems of Polypharmacy in Depression, Dis. Nerv. Syst.37: 30–34 (March) 1976.
21.
DunnerD. L.FieveR. R.: Clinical Factors in Lithium Carbonate Prophylaxis Failure, Arch. Gen. Psychiatry30: 229–233 (Feb.) 1974.
22.
PolatinP.FieveR. R.: Patient Rejection of Lithium Carbonate Prophylaxis, J. Am. Med. Assoc.218: 864–866 (Nov.) 1971.
23.
SpringG. K.: The Current Role of Lithium in the Treatment of Affective Disorders, Psychosomatics17: 151–156 (July-Sept.) 1975.
24.
SingerI.RotenbergD.: Mechanisms of Lithium Actions, N. Engl. J. Med.289: 254–260 (Aug.) 1973.
25.
GlennA. I. M.ReadingH. W.: Regulatory Action of Lithium in Manic-Depressive Illness, Lancet2: 1230–1241 (Dec.) 1973.
26.
MendelsJ.FrazerA.: Alterations in Cell Membrane Activity in Depression, Am. J. Psychiatry131: 1240–1245 (Nov.) 1974.
27.
AkisalH. S.McKinneyW. T.: Overview of Recent Research in Depression, Arch. Gen. Psychiatry32: 285–301 (March) 1975.
28.
MendelsJ.FrazerA.: Brain Biogenic Amine Depletion and Mood, Arch. Gen. Psychiatry30: 447–451 (Apr.) 1974.
29.
AshcrottG.: Modified Amine Hypothesis for the Etiology of Affective Illness, Lancet2: 573–577 (Sept.) 1972.
30.
ColburnR.: Effect of Lithium on the Uptake of Noradrenaline by Synaptosomes, Nature215: 1395–1397 (Sept.) 1967.
31.
FriedmanE.: Effect of Lithium on Brain Dopamine, Nature243: 520–521 (June) 1973.
AmdisenA.: Serum Level Monitoring and Clinical Pharmacokinetics of Lithium, Clin. Pharmacokin.2: 73–92 (Mar.-Apr.) 1977.
34.
GrothU.PrellwitzW.JahuchenE.: Estimation of Pharmacokinetic Parameters of Lithium from Saliva and Urine, Clin. Pharmacol. Ther.16: 490–498 (Sept.) 1974.
35.
PlatmanS. R.: Biochemical Aspects of Lithium in Affective Disorders, Arch. Gen. Psychiatry19: 659 (Dec.) 1968.
36.
FryoB.PettersonU.SedvallG.: Pharmacokinetics of Lithium in Manic-Depressive Patients, Acta Psych. Scand.49: 237–247, 1973.
37.
GreeneR. J.: Clinical Pharmaceutical Aspects of Lithium Therapy, Drug Intell. Clin. Pharm.9: 17–25 (Jan.) 1975.
38.
JarvikM. E., ed.: Psychopharmacology in the Practice of Medicine, Appleton, Century Crofts, New York, pp. 257–259, 1977.
39.
UsdinE.ForrestI. S., eds.: Psychotherapeutic Drugs, Part II, Marcel Dekker, New York, chap. 9, 1977.
40.
SchwinghammerT. L.: A Review of Lithium Therapy, U. S. Pharm.1: 40–45 (Nov.-Dec.) 1976.
41.
PaykelE. S.CoppenA., eds.: Psychopharmacology of Affective Disorders, Oxford University Press, Oxford, chaps. 9 and 12, 1979.